Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as antiΒdiabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.
Key Metrics
as of Sep 2026
Market Cap 18,317 Cr
P/E 27.90
Div Yield 0.55 %
Book Value βΉ282.00
52w High βΉ1,745.00
52w Low βΉ1,200.00
Face Value βΉ1.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
444.00
277.00
315.00
650.00
579.00
405.00
400.00
437.00
457.00
341.00
324.00
410.00
411.00
Expenses
324.00
256.00
238.00
354.00
362.00
284.00
300.00
294.00
333.00
262.00
250.00
265.00
256.00
Operating Profit
120.00
22.00
77.00
297.00
216.00
121.00
100.00
143.00
123.00
79.00
74.00
144.00
156.00
OPM %
27.00
8.00
25.00
46.00
37.00
30.00
25.00
33.00
27.00
23.00
23.00
35.00
38.00
Other Income
26.00
27.00
10.00
24.00
23.00
17.00
8.00
6.00
5.00
20.00
3.00
7.00
4.00
Depreciation
40.00
39.00
39.00
39.00
38.00
43.00
47.00
46.00
46.00
29.00
28.00
25.00
20.00
Interest
42.00
43.00
45.00
46.00
45.00
53.00
55.00
56.00
56.00
29.00
15.00
7.00
7.00
Profit before tax
64.00
-33.00
4.00
235.00
156.00
41.00
6.00
46.00
27.00
42.00
35.00
120.00
133.00
Tax %
25.00
-74.00
21.00
36.00
36.00
26.00
70.00
39.00
36.00
5.00
9.00
2.00
16.00
Net Profit
48.00
-9.00
3.00
150.00
100.00
30.00
2.00
28.00
17.00
40.00
32.00
118.00
111.00
EPS in Rs
3.49
-0.62
0.23
10.98
7.34
2.24
0.13
2.06
1.25
2.90
2.33
8.66
8.14
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
1,822.00 1,698.00 1,487.00 1,331.00 1,216.00 1,109.00 1,020.00 897.00 761.00 713.00 605.00 548.00
Expenses
1,209.00 1,210.00 1,031.00 825.00 727.00 691.00 661.00 562.00 445.00 442.00 435.00 437.00
Operating Profit
612.00 487.00 456.00 506.00 488.00 417.00 359.00 334.00 316.00 271.00 171.00 111.00
OPM %
34.00 29.00 31.00 38.00 40.00 38.00 35.00 37.00 42.00 38.00 28.00 20.00
Other Income
84.00 35.00 33.00 16.00 25.00 10.00 11.00 32.00 28.00 25.00 3.00 7.00
Interest
180.00 220.00 57.00 21.00 3.00 1.00 2.00 23.00 10.00 1.00 0.00 0.00
Depreciation
154.00 182.00 102.00 65.00 51.00 38.00 45.00 32.00 22.00 21.00 20.00 15.00
Profit before tax
362.00 120.00 329.00 437.00 459.00 389.00 324.00 312.00 312.00 274.00 154.00 103.00
Tax %
33.00 36.00 9.00 9.00 9.00 10.00 10.00 8.00 6.00 9.00 10.00 19.00
Net Profit
244.00 77.00 300.00 398.00 417.00 351.00 291.00 285.00 294.00 248.00 138.00 83.00
EPS in Rs
17.62 5.68 22.03 29.27 30.69 25.82 21.45 20.75 21.36 18.05 10,034.18 6,060.36
Dividend Payout %
41.00 129.00 0.00 25.00 20.00 21.00 13.00 0.00 0.00 0.00 61.00 0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
14.00 14.00 14.00 14.00 14.00 14.00 14.00 14.00 14.00 14.00 0.14 0.14
Reserves
3,182.00 2,501.00 2,510.00 2,208.00 1,905.00 1,562.00 1,286.00 1,142.00 854.00 561.00 305.00 267.00
Borrowings
2,101.00 2,245.00 2,572.00 317.00 0.00 0.00 0.00 176.00 376.00 0.00 0.00 1.00
Other Liabilities
481.00 463.00 254.00 245.00 232.00 179.00 183.00 138.00 126.00 82.00 96.00 86.00
Total Liabilities
5,778.00 5,222.00 5,350.00 2,784.00 2,150.00 1,755.00 1,483.00 1,470.00 1,370.00 657.00 402.00 354.00
Fixed Assets
2,353.00 2,412.00 1,516.00 898.00 642.00 584.00 601.00 484.00 490.00 92.00 65.00 61.00
CWIP
0.00 0.00 1.00 0.00 3.00 2.00 4.00 3.00 0.00 0.00 0.00 0.00
Investments
1,414.00 991.00 1,619.00 997.00 778.00 531.00 320.00 580.00 546.00 381.00 206.00 182.00
Other Assets
2,011.00 1,819.00 2,214.00 889.00 728.00 638.00 558.00 403.00 335.00 184.00 131.00 110.00
Total Assets
5,778.00 5,222.00 5,350.00 2,784.00 2,150.00 1,755.00 1,483.00 1,470.00 1,370.00 657.00 402.00 354.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
564.00 702.00 336.00 322.00 369.00 395.00 265.00 216.00 236.00 210.00 133.00 92.00
Cash from Investing Activity
-694.00 -359.00 -2,492.00 -513.00 -268.00 -348.00 127.00 2.00 -593.00 -199.00 -45.00 -94.00
Cash from Financing Activity
71.00 -310.00 2,160.00 194.00 -88.00 -81.00 -334.00 -221.00 363.00 -18.00 -84.00 1.00
Net Cash Flow
-59.00 32.00 4.00 3.00 13.00 -34.00 58.00 -2.00 7.00 -6.00 4.00 -1.00
Free Cash Flow
515.00 694.00 -13.00 11.00 317.00 370.00 121.00 180.00 212.00 161.00 109.00 79.00
CFO/OP %
104.00 147.00 90.00 79.00 93.00 111.00 88.00 86.00 96.00 97.00 96.00 104.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
62.00 51.00 59.00 63.00 41.00 37.00 50.00 31.00 29.00 21.00 15.00 16.00
Inventory Days
71.00 140.00 119.00 98.00 155.00 119.00 145.00 206.00 194.00 161.00 156.00 181.00
Days Payable
128.00 158.00 143.00 128.00 177.00 159.00 200.00 207.00 266.00 86.00 88.00 121.00
Cash Conversion Cycle
4.00 33.00 35.00 33.00 19.00 -3.00 -4.00 30.00 -43.00 97.00 84.00 75.00
Working Capital Days
-145.00 -99.00 -413.00 52.00 80.00 65.00 58.00 -22.00 2.00 31.00 8.00 13.00
ROCE %
11.00 7.00 10.00 20.00 27.00 27.00 24.00 26.00 35.00 62.00 53.00 44.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
54.14
53.92
54.85
54.85
54.83
54.85
54.86
54.87
54.88
54.90
54.90
54.91
FIIs
5.76
6.39
6.85
7.21
8.39
8.43
8.36
8.01
14.59
14.27
13.13
13.20
DIIs
20.71
20.35
20.31
19.36
18.18
18.07
18.07
18.64
16.23
15.63
14.55
14.52
Public
19.39
19.33
17.97
18.57
18.59
18.64
18.73
18.47
14.30
15.20
17.41
17.37
No. of Shareholders
50,798
51,656
54,713
59,438
52,225
50,087
53,314
46,346
44,176
51,753
46,496
42,245
Corporate Actions
16 records
Back to all stocks